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Mutations of the gene expressing plasma membrane transporter for thyroid hormones MCT8
(SLC16A2) in humans lead to altered thyroid hormone levels and a severe neurodevelopmental
disorder. Genetically engineered defect of theMct8 gene inmice leads to similar thyroid hormone
abnormalities but no obvious impairment of brain development or function. In this work we
studied the relative role of the blood-brain barrier and the neuronal plasma cell membrane in the
restricted access of T3 to the target neurons. To this end we compared the effects of low doses of
T4 and T3 on cerebellar structure and gene expression in wild-type (Wt) and Mct8 null male mice
[Mct8-/y, knockout (KO)]made hypothyroid during the neonatal period.We found that compared
with Wt animals, T4 was considerably more potent than T3 in the Mct8KO mice, indicating a
restricted access of T3, but not T4, to neurons after systemic administration in vivo. In contrast, T3
action in cultured cerebellar neurons was similar inWt cells as inMct8KO cells. The results suggest
that the main restriction for T3 entry into the neural target cells of the mouse deficient in Mct8 is
at the blood-brain barrier. (Endocrinology 150: 2491–2496, 2009)
The importance of plasma membrane transporters for thetransfer of thyroidhormones from the extracellularmilieu to
the interior of the cell is now widely recognized. For many years
it was thought that thyroid hormones enter the target cells by
passive or facilitated diffusion. However mutations in a specific
T4 and T3 transporter, the monocarboxylate transporter 8
(MCT8, SlC16A2), were found in patients with a severe neuro-
developmental defect and abnormal levels of iodothyronines in
blood, consistingof decreasedT4and rT3 and increasedT3 (1, 2).
These and subsequent findings revealed the physiological role of
transporters in thyroid hormone action and their relevance to the
brain (3–5).
The generation of Mct8 knockout (KO) mice demonstrated
that absence ofMct8 impairs brain thyroid hormone uptake and
metabolism, possibly due to a primary decreased uptake and
degradation of T3 in target neurons (6, 7). As a consequence, T3
concentrations increase in serum, with stimulation of Dio1 ex-
pression in liver and other tissues. It is postulated that the in-
creased Dio1 activity increases conversion of T4 to T3, thereby
decreasing T4 and further increasing T3 in serum. On the other
hand, circulating rT3 is also decreased, which might be due to
increased degradation byDio1 and/or decreased formation from
T4 by inner ring deiodination.
However, whereas the absence of Mct8 in mice reproduces
the endocrine changes characteristic for humans with MCT8
gene mutations, the mutant mice do not show signs of neuro-
logical impairment, which contrasts with the observations in
humans. It is logical to think that the neurological syndrome is
due to impaired T3 action in neurons as a consequence of re-
stricted uptake. However, no histological changes suggestive of
cerebral hypothyroidism in the mutant mice have been found,
and only amoderately decreased expression of thyroid hormone
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regulated genes such as neurogranin (Nrgn, also known as RC3)
couldbe related to the decreasedT3uptake (6, 7).At least in part,
this could be interpreted as if the mice brains were in a state of
locally compensated hypothyroidism because Dio2 activity is
increased in the brain due to the decreased concentration of cir-
culating T4 (6, 7).
Early studies on Mct8 gene expression in rodents indicated
that the gene is expressed predominantly in the choroid plexuses
and in neurons (8). Recent studies have shown thatMct8 is also
expressed in the blood-brain barrier (9). Other thyroid hormone
transporters are expressed in the blood-brain barrier, such as
organic anion transporters and L-type amino acid transporters
(10, 11). In the absence ofMct8, the restriction to T3 transport
through the blood-brain barrier or through the neuronal
plasma membrane would depend on the presence of alterna-
tive transporters.
In this work, we studied the relevance of Mct8 gene expres-
sion in neurons for T3 action. We have analyzed the relative
effects of low doses of T4 and T3 on two T3 target genes, ex-
pressed in the striatum (Nrgn) and cerebellum [Hairless (Hr)].
We found that in male Mct8KO mice, when compared with
wild-type (Wt)mice, thesegenesare less responsive toT3 thanT4,
indicating a restricted entry of plasmaT3but notT3derived from
T4. On the other hand, the action of T3 in primary cultures of
cerebellar granular cells was little affected in the absence of
Mct8. The data suggest that the critical restriction to T3 trans-
port in the absence of Mct8 is located at the blood-brain barrier
rather than at the plasma membrane of individual neurons.
Materials and Methods
Animals
Protocols for animal handling were approved by the local institu-
tional Animal Care Committee, and followed the rules of the European
Union. Animals were housed in temperature- (22 2 C) and light (12 h
light, 12 h dark cycle; lights on at 0700 h)-controlled conditions and had
free access to food andwater.Mct8KOmicewere originally produced by
Dumitrescu et al. (6) by homologous recombination. Experiments were
carried out onWt (Mct8/y) and KO (Mct8-/y) male litter mates derived
from the third and fourth back crossing of heterozygous females
(Mct8/) with Wt (Mct8/y) males of the C57BL/6J strain. The geno-
type was confirmed by PCR of tail DNA (38 cycles at 55 C annealing
temperature) using the following primers: forward common, 5-ACAA-
CAAAA AGCCAAGCATT-3; reverse Wt specific, 3-GAGAG-
CAGCGTAAGGACAAA-5; reverse knockout specific, 3-CTCCCA
AGCCTGATTTCTAT-5. Using this procedure the Wt allele generated
a 476-bp products and the null allele a 239-bp PCR product.
Induction of hypothyroidism and thyroid hormone
treatments
After crossing with Wt male mice, Mct8/ pregnant dams were
given either drinking water or a solution containing 0.02% 1-methyl-
2-mercapto-imidazol (Sigma Chemical Co., St. Louis, MO) plus 1%
KClO4 ad libitum. These antithyroid drugs were given from gestational
d 17, and throughout the lactating period, until the endof the experiment
on postnatal day (P) 21. The pups were genotyped on P11 to select for
Mct8/y and Mct8/y mice from the same litters. For simplicity, these
animals will be referred to asWt and KOmice, respectively, throughout
this paper. The hypothyroid pups were then divided into three groups
receiving no hormonal treatment, 20 ng T4 per gram body weight, or 3
ng T3 per gram body weight respectively. The hormones were adminis-
tered in PBS containing 0.1% BSA, as daily single ip injections from P16
to P20. The following groups were thus prepared: euthyroid (n 7) and
hypothyroid (n 6) Wt mice; euthyroid (n 8) and hypothyroid (n 6)
KOmice; hypothyroidWtmice treatedwith either T4 (n 5) or T3 (n 6),
and hypothyroid KOmice treatedwith either T4 (n 6) or T3 (n 6). The
pupswerekilledbydecapitation24hafter the lastT4orT3 injection,onP21.
The striatum and cerebellum were rapidly dissected out, frozen on dry ice,
and kept at80 C until RNA isolation.
Histological methods
Examination of stained sections of the cerebellum and in situmRNA
hybridization analysis were performed on pups perfused with para-
formaldehyde under anesthesia. Methods for perfusion, sectioning,
staining, and in situ hybridization have been previously described in
detail (12, 13).
PCR
Total RNA was extracted using the TRIZOL reagent (Invitrogen,
Carlsbad, CA). cDNA was prepared from 250 ng RNA using the high
capacity cDNA reverse transcription kit (Applied Biosystems, Foster
City, CA). For quantitative PCR, a cDNA aliquot corresponding to 5 ng
of the starting RNAwas used, with Taqman Assay-on-Demand primers
and the Taqman universal PCR master mix, No Amp Erase UNG (Ap-
plied Biosystems), on a 7900HT fast real-time PCR system (Applied
Biosystems). The PCR program consisted in a hot start of 95 C for 10
min, followedby40 cycles of 15 sec at 95Cand1min at 60C. PCRswere
performed in triplicates, using the 18S gene as internal standard and the
2-cycle threshold method for analysis. For quantitative assays, a stan-
dard curve was generated after amplification of known amounts of spe-
cific templates for each gene including 18S to calculate the number of
mRNA copies in each sample.
Primary granular cell cultures
All media were purchased from Invitrogen. The cerebella were dis-
sected fromP6-P7Wt andMct8KOmice inHanks’ balanced sodium salt
solution, without Ca2 and Mg2, supplemented with 1 mM Na pyru-
vate and 10 mMHEPES (pH 7.4). The tissue was disaggregated by pass-
ing through a 0.9-mm syringe, rinsed in Hanks’ balanced sodium salt
solution/pyruvate/HEPES and resuspended in serum-free culture me-
dium (neurobasal medium supplemented with 2% B27, 0.5 mM glu-
tamine, 10 U/ml penicillin, and 10 U/ml streptomycin) before seeding on
poly-L-ornithine (Sigma)-coated 12-well multiwells (Sigma; 2.5  105
cells/well). After 4 d, the granular cells were incubated for 24 h in the
absence or presence or T3 (Sigma) (from0.2 to 5 nM) in the samemedium
containing 0.1% newborn calf serum deprived of thyroid hormones.
Astrocyte contamination of the cultures was 3% as determined by im-
munofluorescence. Cells plated on glass coverslips were fixed with 4%
paraformaldehyde for 5min and permeabilizedwith 0.2%TritonX-100
in PBS for 5 min and then with methanol at 20 C for 2 min. After
blockingwith 5%nonimmune serum (Vector Laboratories, Burlingame,
CA), the cells were doubly stained by overnight incubation at 4 C with
the following combination of primary antibodies diluted 1:2000: rabbit
polyclonal antiglial fibrillary acidic protein (Dako, Glostrup, Denmark)
for astrocytes andmousemonoclonal anti-NeuN (Chemicon, Temecula,
CA) for neurons. Nuclei were labeled with the nuclear stain 4, 6-dia-
midino-2-phenylindole dihydrochloride.
Statistical calculations
Differences between means were obtained by two-way ANOVA,
with the two factors being genotype and thyroidal state. As post hoc test,
we used the Bonferroni tests using the Graph-Pad Prism software
(http://www.graphpad.com/prism/).
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Results
In this study we examined the relative effects of low doses of T4,
and T3, administered to hypothyroid Wt and Mct8-deficient
mice. The goal of this study was to evaluate the relative role of
Mct8 in the transport of T4 and T3 in the brain in vivo by de-
termining the effects of the hormones on cerebellar structure and
the expression of thyroid hormone-regulated genes. Preliminary
studies using morphological techniques failed to reveal consis-
tent differences between age-matched, Wt, and KOmice during
development that could be related to deficient thyroid hormone
transport into the brain. Although not shown in this paper, we
examined the laminar structure of the cerebral cortex, myelin
protein expression, maturation of glial cells and different classes
of interneurons and Purkinje cells, and number of interneuron
precursors in the cerebellum and found no consistent deficits in
the KO mice. These observations agree with previous studies
reporting no obvious phenotype of cerebral hypothyroidism in
these mice (6, 7).
The next question we addressed was whether the absence of
the Mct8 transporter impaired the biological activities of exog-
enous T4 and T3 selectively. Wt and KO mice were made hypo-
thyroid by administration of antithyroid drugs and received 20
ng/g T4 or 3 ng/g T3 daily for 5 d before the animals were killed
onP21.Thisdosage schedulewas sufficient to completely correct
the delayed migration of granular cells in the cerebellum of hy-
pothyroidmice, as shown inFig. 1:Cerebellar sections fromeach
groupofmicewere stained and examined by opticalmicroscopy.
Migration of granular cells was already completed in the euthy-
roidWt animals by P21 so that the external germinal layer (EGL)
was absent. As expected, the EGL was still present in the hy-
pothyroidWtmice at this age. Both T4 and T3 treatments were
equally able to prevent the effects of hypothyroidism in the
Wt mice.
In the absence of Mct8, the structure of the cerebellar cortex
in the untreated KOmice was identical with that of theWtmice,
with no EGL remaining, illustrating the lack of morphological
developmental abnormalities. As in the hypothyroid Wt mice,
the EGL was still present in the hypothyroid KO P21 mice. T4
treatment prevented the effects of hypothyroidism. However, in
contrast to the effect onWtmice,T3 treatment didnot correct the
migration abnormality.
To examine the effects of T4, and T3 on gene expression, two
well-known thyroid hormone target genes,Nrgn in the striatum,
andHr in the cerebellum, were examined by real-time PCR. The
results are shown in Fig. 2. Interestingly and despite the lack of
morphological impairment,Hr expression was decreased in the
cerebellum of untreated KO mice with respect to the Wt mice,
with levels similar to those present in WT hypothyroid mice.
Induction of hypothyroidism decreasedHr expression further in
FIG. 1. Effects of hypothyroidism (Hypo) and thyroid hormone treatment on the
structure of the cerebellar cortex of Wt and KO mice. The figure shows
photomicrographs of lobule 7 from toloudine-stained sagittal slices of P21 mice.
Igl, Internal granular layer; Mol, molecular layer. The arrows show the external
germinal layer. Scale bar, 100 m.
FIG. 2. Influence of Mct8 deficit on the response to T4 and T3. Wt and KO mice
were made hypothyroid (Hypo) from the late fetal period up to P21, and treated
with either vehicle or T4 or T3 for 5 d before the animals were killed. Data are
means  SD. Hr and RC3/Nrgn expression was analyzed by real-time PCR in the
cerebellum and striatum, respectively. The data were analyzed by two-way ANOVA
and the Bonferroni posttest to compare the data from each KO condition with the
corresponding Wt. **, P 0.01; ***, P 0.001. For Hr expression, there was a
significant effect of genotype (F1,41 116.01, P 0.0001) and thyroidal status
(F3,41 37.84, P 0.0001), with a significant interaction (F3,41 3.88, P
0.0156). Also for Nrgn, there was a significant effect of genotype (F1,35 24.68,
P 0.0001) and thyroidal status (F3,35 41.16, P 0.0001), with a significant
interaction (F3,35 10.30, P 0.0001). The lower panel shows Gpd2 expression in
the liver. There was a significant effect of thyroidal status (F3,41 23.67, P
0.0001) but not genotype (F3,41 1.065, P 0.308), with a significant interaction
(F3,41 3.936, P 0.0148). NS, Not significant.
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the KOmice. T4 treatment significantly increasedHr expression
in the hypothyroid Wt mice to levels that were similar to the
untreatedWtmice. The effect of T4 treatment in the hypothyroid
KOmice was not different from the hypothyroidWtmice. The
response to T3 was similar to that of T4 in theWtmice but was
significantly different when the hypothyroid Wt and KOmice
were compared. T3 was without effect in the hypothyroid
KO mice.
Nrgn expressionwas also lower in the untreated KO than the
Wtmice and decreased further with hypothyroidism. In contrast
to Hr, the hypothyroid Wt and KO mice had similar Nrgn
mRNA levels. Although neither T4 norT3 treatmentwere able to
fully normalize Nrgn expression, again there was a significant
difference between the responses to T3 between the Wt and the
KO mice but no difference in the responses to T4.
The liver mRNA Gpd2 (encoding mitochondrial -glycerol
phosphate dehydrogenase) was increased in the untreated KO
mice relative to the untreated Wt mice. Hypothyroidism de-
creasedGpd2 expression in both genotypes (P 0.001). T4 and
T3 significantly increased the Gpd2mRNA level compared with
hypothyroid mice (P 0.05). This increase was of similar mag-
nitude in both genotypes and with both hormones.
To correlate the effects of thyroid hormones onHr andNrgn
gene expressionwithMct8 gene expression,weperformed in situ
mRNA hybridization (Fig. 3). The Mct8 gene was heavily ex-
pressed in the choroid plexus (Fig. 3, A–C) and the ependymal
lining of the third ventricle (Fig. 3B). Other sites of expression
were the upper layers of the cerebral cortex, especially the cin-
gulate, visceral, and piriform cortices; the pyramidal and gran-
ular layers of the hippocampus; and the amygdala (Fig. 3B). In
the cerebellum, besides expression in the choroid plexus, Mct8
mRNA had low but detectable abundance in the cerebellar cor-
tex. In the striatumMct8was poorly expressed (Fig. 3A). Figure
3D shows Nrgn mRNA, which is abundantly present after a
lateral-medial gradient, contrasting with the poor expression of
Mct8. The effect ofMct8 gene deletion (Fig. 3E) did not affect the
Nrgn mRNA signal gradient, in contrast to the effect of hypo-
thyroidism (not shown, but see Ref. 14), which results in a total
suppression of the gradient. Interestingly, Dio2 mRNA distri-
bution in the striatum (Fig.3F) also followed a similar gradient,
with no changes in the pattern of distribution in the Mct8 KO
mice (not shown). The lack of correlation between the sites of
expression of Mct8 with that of the T3-target genes, Nrgn and
Hr, indicate that Mct8 might be playing a minor role in thyroid
hormone transport through the plasma membrane of cerebellar
granular cells and striatal neurons in vivo.
Toaddress thisquestionmoredirectly,we studied transporter
expression and Hr induction by T3 in primary cultures of neu-
rons. Granular cells from newbornmice cerebella were cultured.
Toanalyze the effect ofMct8deficit on the effect ofT3onHrgene
induction, T3was added to granular cells fromWt andKOmice,
and Hr mRNA was measured by quantitative PCR. One repre-
sentative experiment using different concentrations of T3 is
shown in Fig. 4. Starting at the lowest concentration used, 0.2
nM, all T3 concentrations gave a significant stimulation of Hr
expression (P 0.001) in both theWt and KO cells. There were
no significant differences in the effect of T3 in the KO mice as
compared with the Wt except for the 1.25 nM T3 concentration
in this particular experiment.
We also examined the profile of transporter expression in the
same cultures used to analyze the effect of T3 on Hr. We mea-
sured the amounts of mRNA of organic anion-transporting
polypeptide (Oatp)-2 (Slco1a4),Oatp14 (Slc1c1), andMct8 (Ta-
ble 1). Granular cells from Wt cells expressed predominantly
Mct8 (591  130 mRNA copies, relative to 18S RNA), which
was undetectable in the KO cells. Oatp2 and Oatp14 were ex-
pressed at much lower levels (27.0 9.1 and 7.4 3.4, respec-
FIG. 3. 35S in situ hybridization for Mct8 (A–C), Nrgn (D and E) and Dio2 (F)
mRNAs. The slices are from coronal sections at the level of the caudate (A, B, and
D–F) and sagittal section of the cerebellum (C). All slices are from P21 Wt mice
except for E, which shows the typical Nrgn expression in a P21 KO mouse. The
arrows in A–C show heavy Mct8 expression in the choroid plexus. The asterisks
show the caudate nucleus in A, with low hybridization signal, and the faint but
detectable hybridization in the cerebellar cortex in C. 3V, Third ventricle.
FIG. 4. Hr expression in primary cultures of granular cells from Wt or Mct8-
deficient mice, as a function of T3 added to the cultures. Differences in Hr
expression between the cells without T3 added and the 0.2 nM T3 concentration
were P  0.001 (a). Differences between the Wt and KO cells at each T3
concentration, by two-way ANOVA were not significant, except for the 0.25 nM
T3, with P  0.05 (b).
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tively). There were no changes in the KO comparedwith theWt,
and T3 treatment had no effects on transporter expression, ex-
cept for the higher dose, which decreased Oatp14 mRNA in the
KO mice.
Discussion
Themain finding of the present work is that the brain of animals
lacking the thyroid hormone transporter Mct8 do not readily
respond to a low dose of T3, whereas the sensitivity to an equally
low dose of T4 is similar to that of Wt animals. Five nanograms
per gram T3 were previously shown to normalize circulating
TSH and hypothalamic TRH transcripts in hypothyroid Wt but
not hypothyroidMct8KOmice (7).We used lowdoses of T4 and
T3 to avoid inhibition of Dio2 by T4 and the use of low-affinity
transporters by T3. Although, based on Gpd2 gene expression,
the doses used did not fully restore euthyroidism in the Wt
mice liver, they were sufficient to normalize cerebellar devel-
opment, EGL migration, and Hr expression in the Wt hypo-
thyroid mice. In contrast, they were insufficient for Nrgn
mRNA normalization.
In normal animals, T3 reaches the extracellular fluid of the
brain parenchyma from the circulation through the blood-brain
barrier and acts directly on the neurons. T4 may exert some
extranuclear actions, but the bulk of genomic responses are me-
diated by its conversion to T3 byDio2. In the brain, this reaction
takes place predominantly in glial cells, namely astrocytes, and
IV ventricle tanycytes, although Dio2 expression has also been
observed in some cerebral cortex interneurons as a response to
hypothyroidism (13, 15).
In the developing cerebellum, T4 to T3 conversion takes place
in the protoplasmic astrocytes located within the granular layer
in close association to the granular cells. Because there was no
difference in the effects of T4 in KO vs. Wt mice, the results
suggest that, in the doses used, T4 could reach the cerebellar
astrocytes of Mct8-deficient mice in sufficient amount to pro-
duce the effects observed in Wt mice. This event is further facil-
itated by the great increase of Dio2 activity in the brain ofMct8
KO mice (6, 7). In addition, the results also suggest that the T3
produced in astrocytes can access the granular cell nuclear re-
ceptors with little restriction at the neuronal cell membrane.
The effects of T3 on granular cells in culture agree with the
above conclusion. Trajkovic et al. (7) also showed that T3 was
effective in inducing Purkinje cell differentiation in vitro in the
presence or absence of Mct8. In the context of these findings, it
was surprising that in isolated granular cells theMct8 gene was
by far the more abundantly expressed transporter. However, its
absence inMct8/y cells caused only aminimal impairment of T3
action at the nuclear level, as evidenced by Hr gene expression,
with a trend toward a lower effect at intermediate doses in the
KO cells. Although expression of other transporters was much
lower, it was enough to elicit almost identical responses to T3 in
the absence as in the presence of Mct8. The presence of other
transporters is also likely the cause for the similar effect of T4 in
vivo inWt and KOmice. The relative effects of T4 and T3 on the
expression of the Nrgn gene in the striatum suggests a similar
conclusion.
These results agree with the preferential accumulation of ad-
ministered T4, relative to the restricted accumulation of admin-
istered T3 in the brain of Mct8 KO mice (6, 7). Brain T3 con-
centrations in the KO mice were about two thirds of normal.
Given the restriction to T3 entry, most T3 in the brain of these
animals must be derived from T4.
The main site ofMct8 expression is the choroid plexus. The
consequences of the absence of Mct8 in the choroid plexus are
not known. Intrathecally administered T4 and T3 can access
brain structures (16). However, most studies on the routes of
thyroid hormone entry to the brain agree that the cerebrospinal
fluid allows only limited access of thyroid hormone to the brain
parenchyma, preferentially reaching cells located near the sur-
face of the ventricles (17, 18). Therefore, the main access of
thyroid hormone to the brain parenchyma is through the blood-
brain barrier. In keeping with this concept, our data suggest that
the restriction of T3 entry inMct8-deficient mice is at the blood-
brain barrier. IndeedMct8has been recently demonstrated in the
membrane of the brain parenchyma capillaries (9). The presence
of other transporters such as Oatp14 and Oatp2, with more
affinity for T4 than T3 may explain the different sensitivities to
T4 and T3. Whereas normal T4 uptake may preserve the com-
pensated phenotype in mice, the lack of alternative transporters
in the human blood-brain barrier would be the reason for the
neurological impairment (9).
In conclusion, the data show that the main restriction to T3
action in the absence of Mct8 is at the level of the blood-brain
barrier. The thyroid hormone transport role of Mct8 in the
TABLE 1. Effect of T3 treatment on transporter expression in cultured granular cells
Transporter mRNA
No T3 2.5 nM T3 5.0 nM T3
Wt KO Wt KO Wt KO
Mct8 591  130 596  48 621  109
Oatp2 27.0  9.1 28.0  8.5 29.3  5.4 23.9  6.1 28.3  1.6 19.5  4.7
Oatp14 7.4  3.4 6.8  2.4 4.9  0.9 2.8  0.4 5.9  1.7 2.5  0.3a
Primary cultures of granular cells from the cerebella of Wt and Mct8 KO mice were incubated in the presence of 0, 0.2, 0.5, 1.25, 2.5, and 5.0 nM T3 for 24 h.
Expression of Mct8 (Slc16a2), Oatp2 (Slco1a4), and Oatp14 (Slc1c1) was quantified by real-time PCR using TaqMan probes. Shown are the data (mean number of RNA
copies relative to 18S RNA  SD) from cells incubated without added T3 or in the presence of 2.5 and 5.0 nM only. Mct8 mRNA was not detected in the KO cells. The
cells used in this experiment are the same as for Hr mRNA quantification shown in Fig. 4. Two-way ANOVA using the data from all T3 concentrations revealed that
there was no difference of genotype or treatment, except for the highest T3 dose that decreased Oatp14 mRNA in the KO cells.
a P  0.05.
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plasma membrane of neurons, at least in the striatum and the
cerebellum, seems to be minimal.
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